Pontiac General Hospital selects OpenVista healthcare IT platform

Cara Livernois | | Health Exec | EMR/EHR

Medsphere Systems Corporation, a provider of electronic health record (EHR) solutions, has announced that Pontiac General Hospital has selected the OpenVista® electronic health record (EHR) system for implementation to improve management practices and clinical workflows as they also grow clinical staff and expand available services.

"Pontiac General will become a thriving community healthcare organization through the implementation of proven practices and tools like the OpenVista EHR," said Sanyam Sharma, owner of Sant Partners, which has invested heavily in the facility. “We chose OpenVista because it gives us the functionality and clinical support we need at a price point that makes sense for a hospital that is investing in all areas of the organization, not just healthcare IT. Some of the better known solutions were just not financially realistic for us, but they also don’t make sense because the costs are not justifiable when compared with everything Medsphere and OpenVista bring to the table.”

OpenVista is a comprehensive EHR platform combining both clinical and financial applications. 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup